Board of Directors

M. Rémi RABEUF

MSc, MBA

CEO

Mr. Rabeuf spent 20 years at Roche where his last position led him to deploy a comprehensive international approach involving Diagnostics and Pharmaceuticals divisions. He brings his vision and expertise in the deployment of the strategy and the overall offer.

M. Thierry GERARDI

MBA IAE Sorbonne

Corporate Secretary 

Mr. Gerardi has extensive experience in business management and strategic consulting. He brings his expertise to define the strategy of value development.

M. Thierry DELVIENNE

Pharm. D., BioQuanta Corp. representative

Senior Management Business Developer Europe LGC

Mr. Delvienne has significant experience in the growth of service-oriented biotechnology and pharmaceutical companies. He has planned the commercialization of the service platforms (MultiDIP® and Mitoxis®) and has manages contacts with partners and potential clients.

M. François HAMON

Pharm. D.

Market Finance, Biotechnology/Pharmaceutical

Mr. Hamon has significant experience as an analyst in the biotech and pharma sector. His relations with the financial community leverage his knowledge for the capital acquisition of BioQuanta.